Literature DB >> 2994794

A retrospective study of male breast cancer in Holland.

A N van Geel, E A van Slooten, M Mavrunac, A A Hart.   

Abstract

A retrospective study has been undertaken of 104 men with breast cancer, all of them having a follow-up period of at least 5 years. In 78 cases a histological diagnosis was obtained. The preferred treatment for operable cases was radical mastectomy, in which 60 per cent positive axillary nodes were found. Five-year survival is 54 per cent and the disease-free interval is 42 per cent. Local recurrence occurred in 26 per cent and 16 per cent had developed distant metastases. The overall results are similar to those in the literature with the exception of those for stage III who did better in this series. The generally held beliefs that Klinefelter's syndrome is the strongest predisposing factor to developing male breast cancer and that gynaecomastia is not a premalignant condition are supported by this study. Comparison of results from this series, with those of women of the same age having breast cancer leads to the conclusion that the prognosis in male breast cancer is no worse than for women with comparable disease.

Entities:  

Mesh:

Year:  1985        PMID: 2994794     DOI: 10.1002/bjs.1800720918

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Genetic abnormalities and CNS tumors: report of two cases of ependymoma associated with Klinefelter's Syndrome (KS).

Authors:  M L Garrè; V Capra; E Di Battista; L Giampietri; P Nozza; A Raso; A Pezzolo; A Rossi; C Milanaccio; M Pavanello; A Naselli
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

Review 2.  Male Breast Cancer.

Authors:  Metin Yalaza; Aydın İnan; Mikdat Bozer
Journal:  J Breast Health       Date:  2016-01-01

3.  Multidisciplinary meeting on male breast cancer: summary and research recommendations.

Authors:  Larissa A Korde; Jo Anne Zujewski; Leah Kamin; Sharon Giordano; Susan Domchek; William F Anderson; John M S Bartlett; Karen Gelmon; Zeina Nahleh; Jonas Bergh; Bruno Cutuli; Giancarlo Pruneri; Worta McCaskill-Stevens; Julie Gralow; Gabriel Hortobagyi; Fatima Cardoso
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

4.  Male breast cancer: Austrian experience.

Authors:  M Stierer; H Rosen; W Weitensfelder; H Hausmaninger; B Teleky; R Jakesz; H Fruhwirth; M Dünser; S Beller; A Haid
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

5.  Current management of male breast cancer. A review of 104 cases.

Authors:  P I Borgen; G Y Wong; V Vlamis; C Potter; B Hoffmann; D W Kinne; M P Osborne; W M McKinnon
Journal:  Ann Surg       Date:  1992-05       Impact factor: 12.969

6.  Survival of male breast cancer in fars, South of iran.

Authors:  A Salehi; H Zeraati; K Mohammad; M Mahmoudi; A R Talei; A Ghaderi; M H Imanieh; A Fotouhi
Journal:  Iran Red Crescent Med J       Date:  2011-02-01       Impact factor: 0.611

7.  Male breast cancer: a review.

Authors:  Is Fentiman
Journal:  Ecancermedicalscience       Date:  2009-03-20

8.  Clinicopathological study of male breast carcinoma: 24 years of experience.

Authors:  Parveen Shah; Irfan Robbani; Omar Shah
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.